In a move to strengthen the Philippines’ fight against animal diseases such as African swine fever (ASF), Senate Majority Leader Francis Tolentino is advocating for the establishment of the Virology Institute of the Philippines (VIP). On January 30, 2025, Tolentino highlighted the necessity of the VIP, which is proposed under Senate Bill 2893, to streamline the country’s efforts against ASF and other animal-borne diseases.
Tolentino’s push comes after observing the inefficiencies in the current system, particularly with the Food and Drug Administration’s slow progress in conducting clinical trials for ASF vaccines. He noted that the trials, once started, were conducted en masse, which he believes could have been more efficiently managed.
The proposed VIP aims to foster seamless collaboration with the Research Institute for Tropical Medicine and other research entities. The goal is to define clear roles and responsibilities to avoid duplication of efforts and ensure a cohesive research agenda. Tolentino envisions the VIP not only coordinating among government agencies but also engaging with private sector laboratories, including those in universities and pharmaceutical companies.
If established, the VIP would be an attached agency of the Department of Science and Technology, leading research and development in virology. This would cover viruses and pathogens affecting plants, animals, and humans. The institute’s mandate includes implementing policies and programs to advance virology and promote scientific and technological activities across both public and private sectors.
The ultimate aim of the VIP, as outlined in the bill, is to apply research outcomes towards achieving vaccine self-reliance and to boost economic and social development, thereby protecting the nation’s citizens and resources.